Liquidia Corporation
$37.66
▲
0.56%
2026-04-21 07:58:00
www.liquidia.com
NCM: LQDA
Explore Liquidia Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$3.32 B
Current Price
$37.66
52W High / Low
$46.67 / $11.85
Stock P/E
—
Book Value
$0.51
Dividend Yield
—
ROCE
-26.74%
ROE
-1.11%
Face Value
—
EPS
$-0.8
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
216
Beta
0.46
Debt / Equity
442.31
Current Ratio
2.01
Quick Ratio
1.84
Forward P/E
7.36
Price / Sales
21.46
Enterprise Value
$3.4 B
EV / EBITDA
-67.61
EV / Revenue
21.5
Rating
Buy
Target Price
$50.67
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | cbdMD, Inc. | $0.81 | — | $7.12 M | 0% | -29.93% | -43.36% | $2.56 / $0.47 | $0.89 |
| 2. | Canopy Growth Corporation | $1.2 | — | $709.79 M | — | -8.06% | -48.5% | $3.28 / $1.18 | $1.49 |
| 3. | Alpha Teknova, Inc. | $2.91 | — | $157.01 M | — | -17.67% | -22.83% | $7.48 / $1.91 | $1.28 |
| 4. | Rockwell Medical, Inc. | $0.94 | — | $37.03 M | — | -9.86% | -15.28% | $2.1 / $0.78 | $0.94 |
| 5. | Cumberland Pharmaceuticals Inc. | $3.15 | — | $47.57 M | — | -6.97% | -12.17% | $6.27 / $1.85 | $1.66 |
| 6. | Organigram Global Inc. | $1.51 | 15.08 | $274.04 M | — | -3.51% | 4.64% | $3.09 / $1.37 | $1.97 |
| 7. | Sunshine Biopharma, Inc. | $1.02 | — | $5.05 M | — | -23.97% | -25.68% | $2.43 / $0.95 | $5.31 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 92.02 M | 54.34 M | 8.84 M | 3.12 M | 2.92 M | — |
| Operating Profit | 19.79 M | 1.77 M | -37.51 M | -35.42 M | -36.11 M | — |
| Net Profit | 14.55 M | -3.53 M | -41.58 M | -38.37 M | -38.37 M | — |
| EPS in Rs | 0.17 | -0.04 | -0.47 | -0.44 | -0.44 | -0.4 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 158.32 M | 14 M | 17.49 M | 15.94 M |
| Operating Profit | -51.38 M | -121.29 M | -73.38 M | -38.77 M |
| Net Profit | -68.92 M | -128.29 M | -78.5 M | -41.02 M |
| EPS in Rs | -0.78 | -1.46 | -0.89 | -0.47 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 327.93 M | 230.31 M | 118.33 M | 129.2 M |
| Total Liabilities | 283.19 M | 150.94 M | 71.04 M | 38.78 M |
| Equity | 44.75 M | 79.38 M | 47.29 M | 90.42 M |
| Current Assets | 273.4 M | 185.1 M | 89.9 M | 99.81 M |
| Current Liabilities | 135.77 M | 41.78 M | 18.55 M | 8.8 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -35.69 M | -93.42 M | -41.56 M | -28.59 M |
| Investing CF | -6.34 M | -8.44 M | -11.29 M | -0.59 M |
| Financing CF | 59.73 M | 194.66 M | 43.25 M | 64.96 M |
| Free CF | -42.02 M | -101.87 M | -52.85 M | -29.18 M |
| Capex | -6.34 M | -8.45 M | -11.29 M | -0.59 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -19.97% | 9.75% | — | — |
| Earnings Growth % | -63.42% | -91.4% | — | — |
| Profit Margin % | -916.63% | -448.89% | -257.39% | — |
| Operating Margin % | -866.63% | -419.62% | -243.3% | — |
| Gross Margin % | 58% | 83.49% | 82.06% | — |
| EBITDA Margin % | -796.25% | -400.57% | -219.83% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.